K921628

Substantially Equivalent

EPSTEIN-BARR VIR EARLY ANTI DIFF IGG CLIN-ELISA

Applicant: Incstar Corp.
Product code: LSE
Advisory panel: Microbiology
Date received: 1992-04-06
Decision date: 1992-09-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.